The Role of p53 Deacetylation in p21Waf1 Regulation by Laminar Flow*

Lingfang Zeng {ddagger}, Yingjia Zhang {ddagger}, Shu Chien §, Xuan Liu ¶ and John Y.-J. Shyy {ddagger} ||

From the {ddagger}Division of Biomedical Sciences and the Department of Biochemistry, University of California, Riverside, California 92521 and the §Department of Bioengineering and the Whitaker Institute of Biomedical Engineering, University of California, San Diego, La Jolla, California 92093

Received for publication, February 25, 2003 , and in revised form, April 17, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Laminar flow arrests vascular endothelial cells at the G0/G1 phase with concurrent increase in p53 and p21Waf1. We investigated the molecular mechanism by which laminar flow activates p53 and p21Waf1 in endothelial cells. The application of a laminar flow (12 dyn/cm2) increased the deacetylation at Lys-320 and Lys-373 of p53 and the acetylation at Lys-382 in human umbilical vein endothelial cells. Laminar flow increased the activity of histone deacetylase (HDAC) and the association of p53 with HDAC1. Treating human umbilical vein endothelial cells with trichostatin A (TSA), an HDAC inhibitor, abolished the flow-induced p53 deacetylation at Lys-320 and Lys-373. To investigate the role of the HDAC-deacetylated p53 in the flow activation of p21Waf1, we found that TSA inhibited the activation at both the mRNA and protein levels. Deletion and mutation analyses of the p21Waf1 promoter revealed that flow activated p21Waf1 through p53 and TSA abrogated this p53-dependent activation. The expression plasmid encoding the p53 mutant, with Lys-320 and Lys-373 replaced by Arg, increased the activity of the co-transfected p21Waf1 promoter, which demonstrates that HDAC-deacetylated p53 can transactivate the p21Waf1 gene. The regulation of the p53-p21Waf1 pathway by laminar flow was further supported by observations that flow caused an increase of p21Waf1 level in the wild-type HCT116 (p53+/+) cells but not in the p53-null HCT116 cells.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
By controlling cell cycle arrest and/or apoptosis, the p53 tumor suppressor plays a critical role in cell proliferation (see Refs. 1 and 2 for review). p53 exerts its functions by activating or repressing the transcription of target genes, including p21Waf1, GADD45, Bax, and MDM2, whose gene products are required either to regulate cell cycle progression or to modulate the function of p53. Several distinct functional domains within p53 have been characterized: an N-terminal transactivation domain (amino acids 1–43), a central domain that binds specific DNA sequences (amino acids 100–300), the C-terminal tetramerization domain (amino acids 320–360), and a regulatory domain (amino acids 363–393). p53 activity is regulated by multiple post-translational modifications. The phosphorylation at Ser-6, Ser-9, Ser-15, Ser-20, Ser-33, Ser-37, Ser-46, Thr-18, and Thr-81 in the N-terminal leads to the stabilization of the p53 protein (see Ref. 3 for review). Phosphorylation at Ser-315 and Ser-392 and the sumoylation at Lys-386 are believed to enhance the binding of p53 to DNA and to elevate p53 transcriptional activity (48).

In response to genotoxic stresses such as UV irradiation, {gamma}-irradiation, and DNA damage agents, p53 is also acetylated at multiple Lys residues (see Ref. 9 for review). The acetylation of Lys is mediated by two distinct classes of histone acetyltransferase. cAMP-responsive element-binding protein-binding protein (CBP1)/p300 acetylates Lys-382 and, to a lesser extent, Lys-373 and Lys-381, whereas CBP/p300-associated factor (PCAF) acetylates Lys-320. The functional consequences of p53 acetylation are still not clearly defined. Both CBP/p300 and PCAF can increase the p53-mediated p21Waf1 gene expression in vivo (4, 10). It has been shown that the acetylation of p53 can increase its DNA binding activity to short DNA sequences in vitro but seems to exert little effect on its binding to long DNA sequences or chromatin DNA (11). p53 is deacetylated by histone deacetylase 1 (HDAC1) or Sir2 (1214). p53 deacetylation has been suggested to down-regulate the activation of genes such as Bax and p21Waf1 (1517).

Blood flow acts on the vascular endothelial cells (ECs), which play a crucial role in cardiovascular physiology and pathophysiology (see Ref. 18 for review). The shear forces result from local blood flow patterns, depending upon the vessel geometry. The regions under laminar flow (i.e. the straight parts of the arterial tree) have been found to be resistant to atherosclerosis, whereas disturbed flow regions at the bends and bifurcations are prone to lesion development (see Ref. 19 for review). The results of in vitro experiments using flow channels have demonstrated that laminar flow protects ECs from apoptosis induced by tumor necrosis factor-{alpha}, oxidized low density lipoprotein, and angiotensin II (20, 21). We and others have shown that laminar flow suppresses the transition from the G1 to S phase and that this is associated with an increase in the expression of p21Waf1 at mRNA and protein levels (22, 23). These changes are accompanied by decreases in the phosphorylation of retinoblastoma protein and in the activities of cdk2 and cdk4.

In view of the importance of p53 and p21Waf1 in cell cycle regulation and flow-induced changes in EC biology, we investigated the mechanisms by which laminar flow regulates p53 and p21Waf1 in ECs. Our results revealed that Lys residues of p53 are differently regulated. Laminar flow leads to an increase in acetylation at Lys-382 but a deacetylation at Lys-320 and Lys-373. This unique pattern of p53 deacetylation contributes, at least in part, to the activation of p21Waf1. These results provide new insights into the roles of p53 in regulating EC functions.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Cell Culture and Stimulation by Laminar Flow or UV Irradiation— Bovine aortic ECs (BAECs) were maintained in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum. Human umbilical vein ECs (HUVECs) were maintained in M199 medium (Invitrogen) supplemented with 25 mM HEPES, 2.5 µg/ml thymidine, 0.1 mg/ml heparin, 5 ng/ml EC growth factor, and 15% fetal bovine serum. The p53-null human colorectal cancer cell line HCT116p53/ and its parental wild-type HCT116p53+/+ were cultured in McCoy's medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin.

For laminar flow experiments, BAECs or HUVECs were cultured on collagen-coated glass slides (38 x 76 mm). The cells were exposed to a laminar flow generated by the pressure difference between the upper and lower reservoirs, with the effluent tissue culture medium circulated back to the upper reservoir through a peristaltic pump. The shear stress, determined by the flow rate and the channel dimensions, was 12 dyn/cm2, which is comparable with the physiological range in human major arteries and has been found to increase the amount of p53 (22). The pH was kept by gassing the flow system with a mixture of 95% air, 5% CO2, and the temperature was maintained at 37 °C. Static controls were cells cultured on slides not exposed to flow. For the UV irradiation experiments, HUVECs were exposed to 100 J/m2 UV irradiation after the medium was removed. Fresh culture media were replenished to the irradiated cells for different lengths of time as indicated.

Plasmids and Transient Transfection—p53K320R/K373R encoding a mutant p53 was constructed by the use of PCR-based mutagenesis with pcDNA1.1-p53 (24) as the template for Arg replacement of Lys-320, Lys-321, Lys-372, and Lys-373. The –2290 to +8 fragment of the p21Waf1 promoter sequence was amplified by PCR using a primer set of 5'-atcggtacccagcaggctgtggctctg-3' and 5'-atcctcgagccctcagctggcgcagc-3'. The amplified fragment was then cloned into the KpnI/XhoI site of the pGL2-basic vector to create plasmid p21-Luc-2290 that contains both the p53 consensus element (–2255 to –2232) and Sp1/Sp3 sites (–50 to 150). p21-Luc-1190, p21-Luc-33, and p21/CE-Luc-33 were created from p21-luc-2290 by deleting the respective fragments of 1.1 kb (–2290 to –1190), 2.26 kb (–2290 to –34) and 2.24 kb (–2233 to –34). p21-Luc-1190 contains only Sp1/Sp3 sites, whereas p21-Luc-33 contains a TATA box with neither p53 element nor Sp1/Sp3 sites. p21/CE-Luc-33 contains only a p53 consensus element.

The various DNA plasmids were transfected into BAECs at 70% confluency using the LipofectAMINE method (Invitrogen). A total of 100 ng of Renilla Luc plasmid was included for transfection efficiency. 12 h after transfection, the cells were passed onto glass slides and cultured for another 12 h before the flow experiments. The firefly luciferase and Renilla luciferase activity were detected by use of standard protocols.

Immunoprecipitation and Immunoblotting—The cells were lysed in TNEN buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, pH 8.0, and 0.2% Nonidet P-40) containing 25 µg/ml N-acetyl-Leu-Leunorleucine-CHO (Calbiochem, San Diego, CA) and a protease inhibitor mixture (Le Roche, Palo Alto, CA). Two micrograms of rabbit anti-p53FL, recognizing amino acids 1–392 of p53 (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-Ace-K320, or rabbit anti-Ace-K373 (Upstate Biotech, Inc., Lake Placid, NY), together with 25 µl of protein A-Sepharose 4B beads, were added to 500 µg of lysates for immunoprecipitation. The immunoprecipitates were washed and separated by SDS-PAGE. After being transferred to the polyvinylidene difluoride membrane, the blot was blocked with 5% nonfat milk in TTBS (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.05% Tween 20) and then incubated with the detecting antibodies in TTBS containing 1% bovine serum albumin. The antibodies used were anti-p53 DO1 mAb, recognizing amino acids 11–25 of p53, anti-HDAC1 mAb, anti-p21Waf1 mAb (Santa Cruz Biotechnology), and rabbit anti-Ace-K382 (Upstate Biotech). The bound primary antibodies were detected with the use of horseradish peroxidase-conjugated secondary antibodies and the ECL detection system (Amersham Biosciences).

HDAC Activity Assay—Histone deacetylase activity was determined by using the histone deacetylase assay kit (Upstate Biotechnology, Inc.). In brief, biotinylated histone H4 peptide was acetylated by PCAF with [3H]Acetyl CoA (Amersham Biosciences) and captured by avidinagarose beads. The cells were lysed by sonication in TNE buffer (TNEN buffer without Nonidet P-40), and 50 µg of the lysates were added to 200 µl of a reaction solution containing 10 mM Tris-HCl, 150 mM NaCl, 10% glycerol, and 2 x 104 cpm [H3]acetyl-histone peptide, with or without 50 mM sodium butyrate. The reaction mixture was incubated at room temperature on an orbital shaker for 12 h. A total of 50 µl of a quenching solution was added to stop the reaction, and the released [H3]acetate was separated from the H4 peptide beads by centrifugation. The HDAC activity was then determined by radioisotope counting of the supernatant.

Northern Blotting—Total cellular RNA was isolated with Trizole reagents (Invitrogen), and 10 µg of RNA from each sample was separated by formaldehyde agarose gel electrophoresis. After being transferred to a nitrocellulose membrane, the blots were hybridized with cDNA probes labeled with [{alpha}-32P]dCTP, and the hybridized bands were visualized by autoradiography.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Laminar Flow Deacetylates Lys-320 and Lys-373 of p53—By using antibodies recognizing acetylated Lys-320, Lys-373, or Lys-382, we investigated the effect of laminar flow on the acetylation of p53. In HUVECs subjected to laminar flow (12 dyn/cm2), there was decreased acetylation at Lys-320 and Lys-373 and sustained increase in acetylation at Lys-382 (Fig. 1A). In positive control experiments, UV irradiation (100 J/m2) caused an increase in acetylation at Lys-320, Lys-373, and Lys-382. (Fig. 1B). Both laminar flow and UV irradiation increased the level of p53, as revealed by immunoblotting with anti-p53 DO1 mAb. Normalization of the amount of acetylated Lys to that of p53 confirmed that laminar flow deacetylated Lys-320 and Lys-373 but increased the acetylation of Lys-382. In contrast, UV irradiation increased the acetylation of all three Lys residues. Thus, laminar flow and UV irradiation impose different patterns of acetylation on p53.



View larger version (47K):
[in this window]
[in a new window]
 
FIG. 1.
Laminar flow deacetylates p53 in HUVECs. A, HUVECs cultured on glass slides were subjected to laminar flow with shear stress at 12 dyn/cm2 for the indicated durations. B, HUVECs were subjected to UV irradiation with a dose of 100 J/m2 and kept under normal culture conditions for the times indicated. The sheared or irradiated cells were lysed, and the cell lysates were then immunoprecipitated (IP) with anti-Ace-K320 or anti-Ace-K373 followed by SDS-PAGE and immunoblotting (IB) with anti-p53 DO1 mAb. In parallel experiments, the acetylation of Lys-382, {alpha}-tubulin, and total amounts of cellular p53 were revealed by immunoblotting with anti-Ace-K382, anti-{alpha}-tubulin, and anti-p53 DO1, respectively. Time 0 represents control cells not exposed to laminar flow or UV irradiation. The results shown are representative from three separate experiments. The bottom panels are the intensity of the protein bands representing various acetylated Lys and those of anti-p53 DO1-detected p53 determined by densitometry. Ace-Lys/p53 represents the intensities of Ace-Lys-320, Ace-Lys-373, and Ace-Lys-382 normalized to that of p53 with time 0 set as 1.0.

 

p53 Deacetylation in Response to Laminar Flow Is Mediated by HDAC—Because p53 is a substrate of HDAC, we investigated the changes of HDAC activity in response to laminar flow and UV irradiation. As shown in Fig. 2A, laminar flow increased the HDAC activity in HUVECs as early as 2 h and was sustained for at least 8 h. In contrast, UV irradiation had little effect on HDAC activity. To test whether the flow-induced increase in HDAC activity was associated with p53, we studied the effect of laminar flow on the HDAC1-p53 association and on HDAC activity in anti-p53 immunoprecipitates. As shown in Fig. 2B, the application of laminar flow for 4 h increased the amount of HDAC1 co-immunoprecipitated with p53, which reveals an increased association of HDAC1 and p53. Furthermore, the HDAC activity in the immunoprecipitates pulled down by anti-p53 from cells that had been exposed to laminar flow was four times higher than that in static controls, indicating that the p53-associated HDAC was activated by laminar flow (Fig. 2C).



View larger version (26K):
[in this window]
[in a new window]
 
FIG. 2.
Laminar flow increases HDAC1 activity and its association with p53 in HUVECs. A, cells were subjected to laminar flow (12 dyn/cm2) or UV irradiation (100 J/m2) for the times indicated. Fifty micrograms of cell lysates were subjected to HDAC activity assays measuring the released [H3]acetate in cpm from [H3]acetyl-histone peptide. The bar graph represents means ± S.D. from three separate experiments. B, cells subjected to laminar flow or kept under static conditions for 4 h were lysed in TNEN buffer. p53 protein was immunoprecipitated (IP) from 500 µg of cell lysates with rabbit anti-p53FL(1–393) antibody. Rabbit IgG was used in parallel experiments as a control. The p53-associated HDAC1 was detected by immunoblotting (IB) with anti-HDAC1 mAb. A total of 50 µg of cell lysates was used as an input control. The membrane was stripped and reprobed with anti-p53 DO1 antibody to show the level of p53. C, the p53-associated HDAC1 was immunoprecipitated with rabbit anti-p53FL(1–393) followed by HDAC activity assays.

 

To confirm the flow-activated HDAC, we also examined the effect of trichostatin A (TSA), a pharmacological inhibitor of HDAC, on the flow-induced deacetylation at Lys-320 and Lys-373. TSA abolished the flow-increased HDAC activity seen in HUVECs treated with Me2SO, the vehicle control (Fig. 3A). TSA treatment also abolished the flow-induced deacetylation of p53 at Lys-320 and Lys-373 (Fig. 3B).



View larger version (30K):
[in this window]
[in a new window]
 
FIG. 3.
TSA inhibits the deacetylation of p53 in response to laminar flow. HUVECs were treated with Me2SO (DMSO) or TSA (0.3 µM in Me2SO) 2 h prior to the application of laminar flow or kept under static conditions for 4 h. The bars represent the means ± S.D. from three experiments. A, HDAC activity assays were performed on the collected cell lysates. B, the isolated cell lysates were immunoprecipitated (IP) with anti-Ace-K320 or anti-Ace-K373 and then immunoblotted (IB) with anti-p53DO1. In separate sets of experiments, 10% of cell lysates were immunoblotted with anti-p53DO1 or anti-{alpha}-tubulin to ascertain equal loading.

 

Laminar Flow Induction of p21Waf1 Depends on HDAC— p21Waf1, a downstream effector of p53, is up-regulated in ECs exposed to laminar flow (22, 23). To correlate the HDAC activity with the flow-induced p21Waf1, we examined the effect of TSA on the flow regulation of p21Waf1 at both mRNA and protein levels. Results of Northern blotting revealed that laminar flow induced the level of p21Waf1 mRNA in HUVECs by 3.1 ± 0.3-fold (Fig. 4A). Treatment of cells with TSA under static conditions up-regulated p21Waf1 mRNA by 3.3 ± 0.5-fold, which was consistent with the positive effect of TSA on p21Waf1 in ECs, gastric carcinoma cells, and NIH3T3 cells (2527). However, the application of laminar flow to TSA-treated cells did not cause any further increase in the level of p21Waf1 mRNA. Immunoblotting revealed the same pattern of p21Waf1 regulation by laminar flow, TSA, and a combination in which TSA treatment was followed by flow (Fig. 4B). Fig. 4 indicates that TSA pretreatment abolished the flow-enhanced expression of p21Waf1 as a result of the inhibition of HDAC-deacetylated p53.



View larger version (32K):
[in this window]
[in a new window]
 
FIG. 4.
The induction of p21Waf1 by laminar flow is HDAC-dependent. A, HUVECs were subjected to laminar flow for the times indicated (left panel). In a parallel set of experiments, the cells were treated with Me2SO (DMSO) or TSA for 8 h under static conditions or pretreated with TSA followed by laminar flow stimulation in the presence of TSA for the times indicated (right panel). The isolated total RNA (10 µg) was subjected to Northern blotting with the use of a 0.3-kb 32P-labeled p21Waf1 cDNA as the probe. After autoradiography, the membrane was stripped and reprobed with a 0.4-kb 32P-labeled {beta}-actin cDNA. The bottom panels represent the band intensity of the p21Waf1 mRNA normalized to that of {beta}-actin. The asterisk indicates that the comparison is statistically insignificant (p < 005). B, Me2SO- or TSA-treated HUVECs were subjected to laminar flow for 4 h or kept under static conditions for the same duration. A total of 50 µg of the isolated proteins was immunoblotted with anti-p21Waf1 or anti-{alpha}-tubulin. The bottom panel shows the intensity of p21Waf1 normalized to that of {alpha}-tubulin averaged from three experiments.

 

The Induction of p21Waf1 by Laminar Flow Is p53-dependent—Because TSA could induce p21Waf1 under static conditions but inhibited the flow-induced p21Waf1, we manipulated the sites in the p21Waf1 promoter constructs that respond to p53 and TSA to reinforce the observation that distinct mechanisms are involved in the induction of p21Waf1 by laminar flow and by TSA. Compared with Me2SO treatment, both laminar flow and TSA induced the luciferase activity of p21-Luc-2290, in which the luciferase reporter is driven by the 2.3-kb promoter region of the p21Waf1 gene, by 4.5 ± 0.8 and 5.5 ± 0.5-fold, respectively. However, the promoter activity induced by TSA was not further increased by laminar flow (Fig. 5A). Deletion of the N-terminal 1.1 kb that contains the p53-binding site abolished the flow-induced but not the TSA-induced luciferase activity. Further deletion of the Sp1/Sp3 site, which resulted in the –33 to +1 fragment containing only the TATA box of the p21Waf1 promoter, diminished the response to both flow and TSA. Insertion of the sequence aggaacatgtcccaacatgttgag (e.g. the p53 target site) immediately upstream of the –33 to +1 fragment restored the induction of luciferase activity by flow but not by TSA. More importantly, TSA treatment abolished this p53-dependent induction by laminar flow.



View larger version (20K):
[in this window]
[in a new window]
 
FIG. 5.
The laminar flow induction of the p21Waf1 promoter in ECs is regulated by the HDAC-p53 pathway. A, BAECs were transiently transfected with 1 µg of p21-Luc-2290, p21-Luc-1190, p21-Luc-33, or p21/CE-Luc-33, together with Renilla Luc (0.1 µg). The transfected cells were cultured on glass slides for 12 h prior to the treatment of Me2SO (DMSO), laminar flow, TSA, or laminar flow in the presence of TSA for 8 h. The cells were then lysed for firefly and Renilla luciferase activity assays. The firefly luciferase activity was normalized to that of Renilla luciferase averaged from four separate experiments. The bar graphs shown in the right panels are the folds of induction, with the normalized luciferase activity of Me2SO-treated cells set as 1. B, BAECs were transfected with p21-Luc (1 µg) and Renilla Luc (0.1 µg), together with pCDNA3 (1 µg), p53wt (1 µg), or p53K320R/K373R (1 µg). After becoming confluent, the transfected cells were kept under static conditions for 8 h more followed by luciferase activity assays. The bars represent the firefly luciferase activity normalized to that of Renilla luciferase averaged from four separate experiments.

 

To test further the molecular mechanism by which the HDAC1-p53 pathway regulates the transcription of p21Waf1, the expression plasmid p53K320R/K373R was created to encode a p53 mutant in which Lys-320/321 and Lys-372/373 were replaced by Arg. Such a replacement would mimic the deacetylation of these two residues by laminar flow. As shown in Fig. 5B, cells co-transfected with the wild-type p53 expression plasmid showed increased luciferase activity of p21-Luc-2290 by 30 ± 2-fold compared with cells co-transfected with pCDNA3. Co-transfection of p53K320R/K373R further increased the induction of the p21Waf1 promoter (42 ± 5-fold), which indicates the effect of p53 deacetylation on the activation of p21Waf1. Together, Figs. 4 and 5 demonstrate that the laminar flow induction of p21Waf1 in ECs depends on the HDAC deacetylation of p53 at Lys-320 and Lys-373.

By using HCT116p53+/+ cells and its isogenic p53-null cells, we explored further whether p53 is necessary for the laminar flow induction of p21Waf1. The application of laminar flow augmented p21Waf1 in HCT116p53+/+ cells but not in HCT116p53/ cells (Fig. 6). In separate experiments, p21Waf1 was induced by TSA in both cell types. These results indicate that p53 is necessary for the activation of p21Waf1 by laminar flow but not by TSA.



View larger version (56K):
[in this window]
[in a new window]
 
FIG. 6.
Laminar flow induces p21Waf1 in HCT116p53+/+ but not in HCT116p53/ cells. A, HCT116p53+/+ cells and their p53-null counterparts were subjected to laminar flow for the times indicated. A total of 50 µg of the cell lysates was immunoblotted with anti-p21Waf1, anti-p53 DO1, or anti-{alpha}-tubulin antibody. B, HCT116p53+/+ or HCT116p53/ cells were treated with TSA for the times indicated. All control cells were treated with Me2SO for 8 h. p21Waf1 and {alpha}-tubulin protein levels were detected by immunoblotting.

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Laminar flow increases p53 and p21Waf1 in ECs, which is associated with the arrest of cells in the G1 to S phase transition (22, 23). In the current study, we show that laminar flow-induced HDAC can cause the specific deacetylation at Lys-320 and Lys-373 of p53, which leads to the up-regulation of p21Waf1. Previous studies have shown that p53 is acetylated at Lys-320, Lys-373, and Lys-382 in response to genotoxic stresses, including etoposide, a DNA-damaging agent, as well as ionizing and UV irradiation (4, 28). Our data show that laminar flow causes p53 deacetylation at Lys-320 and Lys-373 but acetylation at Lys-382 (Fig. 1A). HDACs are involved in these deacetylation responses, because (a) laminar flow increases the association of p53 with HDAC1 and (b) the p53-associated HDAC1 has an elevated histone deacetylase activity (Fig. 2). The deacetylation of Lys-320 and Lys-373 by HDAC is further supported by the abrogation of deacetylation when TSA is included in flow experiments (Fig. 3B). HDAC2 and HDAC3 also belong to the class I HDAC family, as does HDAC1 (29). Because HDAC2 and HDAC3 can also interact with p53 in vitro and in vivo to regulate its activity through deacetylation (15), laminar flow may also activate HDAC2 and HDAC3.

Interestingly, laminar flow increases Lys-382 acetylation but deacetylates Lys-320 and Lys-373 through the flow-activated HDAC. This pattern of changes in p53 acetylation is different from that induced by UV irradiation, which acetylates p53 at all three sites in ECs (Fig. 1B). CBP/p300 acetylates Lys-382 and to a lesser extent Lys-373, whereas PCAF acetylates Lys-320. One possible explanation for the flow-induced Lys-382 acetylation is that laminar flow also activates the histone acetyltransferase activity of CBP/p300 to cause this change. Does laminar flow activate PCAF, and if so, why does HDAC override PCAF but not CBP/p300? Furthermore, why does CBP/p300 acetylate Lys-382 but not Lys-373, as laminar flow causes Lys-320 and Lys-373 deacetylation? In principle, the acetylation of transcription factors by CBP/p300 and/or PCAF facilitates their access to target genes to activate their expression. In contrast, by removing the acetyl residues from histone, HDAC down-regulates the gene expression. The acetylation status of p53 would be a result of the homeostatic balance between histone acetyltransferases and HDACs (30). It is likely that laminar flow renders a specific conformation of p53 that increases or hinders its access to HDAC, CBP/p300, and PCAF to cause a unique deacetylation/acetylation pattern. Such exquisite regulations may require the coordinated effects of histone acetyltransferase and HDAC on p53.

Several previous studies suggested a positive correlation between p53 acetylation and p21Waf1 expression. Genotoxic stresses or TSA increase both p53 acetylation and p21Waf1 activation (9). The overexpression of HDAC1 or PID decreases the p53 transactivation of p21Waf1 (13, 15, 16). How p53 acetylation affects p21Waf1 transcription is still unclear. A p53 mutant with Lys-320, Lys-373, or Lys-382 substituted by Arg decreases the activity of the co-transfected p21Waf1 promoter construct in Saos-2 cells (4), which suggests that p53 deacetylation at a single Lys residue decreases the p21Waf1 transcription. However, replacement of Lys-320, Lys-373, Lys-381, or Lys-382, or all four sites, with Ala, which is a manipulation that mimics sustained acetylation, has little effect on the level of p21Waf1, although such mutations increase the DNA binding activity of the mutated p53 in vitro (31). Our data demonstrate for the first time that p53 deacetylation at Lys-320 and Lys-373 can activate p21Waf1 (Fig. 5B). When TSA was included in flow experiments, the p53 deacetylation by HDAC was abrogated. Accordingly, the induction of p21Waf1 was attenuated (Figs. 3 and 5A). These results suggest that the deacetylation of p53 at these two Lys residues is necessary for the induction of p21Waf1 by flow. Although deacetylation (Lys-320 and Lys-373) and acetylation (Lys-382) are concurrent in response to laminar flow, p53 can also undergo phosphorylation at Ser-15 and Ser-20 (data not shown). It is likely that a synergistic effect resulting from the intricate coordination of acetylation, deacetylation, and phosphorylation mediates the activation of p21Waf1. Such a synergy is reminiscent of the modulation of p53 acetylation at Lys-382 by phosphorylation at Ser-33 and Ser-37 in response to DNA damage (32).

Both p53-dependent and -independent pathways have been reported to regulate the transcription of p21Waf1. In addition to the p53 consensus element, several Sp1 and Sp3 binding sites exist in the promoter region of the p21Waf1 gene. By inhibiting HDAC to increase p53 acetylation, TSA activates the expression of p21Waf1 through Sp1/Sp3 in a p53-independent manner (26, 27, 33). Laminar flow activates only the p21Waf1 promoter constructs with a functional p53 consensus element (Fig. 5A). In contrast, TSA induction of the p21Waf1 promoter in ECs is mediated through the Sp1/Sp3 sites. Accordingly, laminar flow and TSA activate the p21Waf1 gene through distinct mechanisms. This notion is further supported by the induction of p21Waf1 by laminar flow in HCT116p53+/+ cells but not their p53-null counterparts (Fig. 6). p53-dependent p21Waf1 expression has been observed in the HCT116 cell system in response to c-Jun NH2-terminal kinase perturbation or doxorubicin, a DNA-damaging drug (34, 35). The lack of p21Waf1 in HCT116/p21/ cells has been linked to the increased sensitivity of these cells to apoptosis induced by anti-cancer drugs (36, 37), yet the G1 arrest was completely abrogated in response to DNA damage (38). Thus, the p53-dependent p21Waf1 expression may have dual functions depending upon the types of cells and the stimuli they receive; although the p53-dependent p21Waf1 expression arrests cells in G1/G0, it would also protect the cells from apoptosis.

The ECs at the straight part of the arterial tree are quiescent, whereas ECs at branch points have an accelerated mitotic rate (39). Undisturbed versus disturbed flows associated with vascular geometry have been suggested to play an important role in regulating EC cycle progression. The physiological implication of the current study is that laminar flow, by preventing EC mitosis, can minimize the lipoprotein permeability through the EC junction at the straight part of the vessel. A recent study by Rössig et al. (25) demonstrates that inhibition of HDAC activity is associated with an attenuated expression of endothelial nitric oxide synthase in ECs, as well as impaired vasorelaxation. Thus, the laminar flow-increased HDAC activity may also contribute to an optimal level of eNOS expression. Physiological levels of laminar flow not only arrest the EC cell cycle and increase vessel relaxation but also prevent apoptosis of ECs in response to a variety of stimuli, including tumor necrosis factor-{alpha}, oxidized low density lipoprotein, and angiotensin II (20, 21). Hence, another possible functional consequence of the p21Waf1 up-regulation by the deacetylated p53 is to protect ECs from apoptosis. This possibility is supported by the finding that TSA inhibition of HDAC induces the apoptosis of several cell types such as Huh-7 hepatoma cells and MKN-7 gastric carcinoma cells (26, 40). In line with this concept, we found that the UV-induced apoptosis in ECs transfected with p53K320R/K373R was 50% lower than in cells transfected with the wild-type p53 (data not shown). Through the HDAC1-p53-p21Waf1 pathway, laminar flow-generated mechanotransduction and signaling can arrest ECs at the G0/G1 phase of the cell cycle while preventing apoptosis, which would be beneficial to vascular homeostasis.


    FOOTNOTES
 
* This work was supported in part by NHLBI, National Institutes of Health Grants HL19454, HL43026, and HL64382 (to S. C.) and HL56707 and HL60789 (to J. S.) and NCI, National Institutes of Health Grant CA75180 (to X. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

|| Established Investigator of the American Heart Association. To whom correspondence should be addressed: Div. of Biomedical Sciences, University of California, Riverside, CA 92521-0121. E-mail: john.shyy{at}ucr.edu.

1 The abbreviations used are: CBP, cAMP-responsive element-binding protein-binding protein; PCAF, CBP/p300-associated factor; BAEC, bovine aortic endothelial cell; EC, endothelial cell; HDAC, histone deacetylase; HUVEC, human umbilical vein endothelial cell; TSA, trichostatin A; Luc, luciferase; mAb, monoclonal antibody. Back


    ACKNOWLEDGMENTS
 
We thank Dr. Laurie Owen-Schaub (Division of Biomedical Sciences, University of California, Riverside) for fruitful discussions.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Vogelstein, B., Lane, D., and Levine, A. J. (2000) Nature 408, 307–310[CrossRef][Medline] [Order article via Infotrieve]
  2. Sharpless, N. E., and DePinho, R. A. (2002) Cell 110, 9–12[Medline] [Order article via Infotrieve]
  3. Appella, E., and Anderson, C. W. (2001) Eur. J. Biochem. 268, 2764–2772[Abstract/Free Full Text]
  4. Liu, L., Scolnik, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., and Berger, S. L. (1999) Mol. Cell. Biol. 19, 1202–1209[Abstract/Free Full Text]
  5. Blaydes, J. P., Luciani, M. G., Pospisilova, S., Ball, H. M.-L., Vojtesek, B., and Hupp, T. R. (2000) J. Biol. Chem. 276, 4699–4708[Abstract/Free Full Text]
  6. Kapoor, M., and Lozano, G. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 2834–2837[Abstract/Free Full Text]
  7. Gu, W., and Roeder, R. G. (1997) Cell, 90, 595–606[Medline] [Order article via Infotrieve]
  8. Rodriguez, M. S., Desterro, J. M. P., Lain, S., Midgley, C. A., Lane, D. P., and Hay, R. T. (1999) EMBO J. 18, 6455–6461[Abstract/Free Full Text]
  9. Prives, C., and Manley, J. L. (2001) Cell 107, 815–818[CrossRef][Medline] [Order article via Infotrieve]
  10. Scolnick, D. M., Chehab, N. H., Starvridi, E. S., Lie, M. C., Caruso, L., Moran, E., Berger, S. L., and Halazonetis, T. D. (1997) Cancer Res. 57, 3693–3696[Abstract]
  11. Espinosa, J. M., and Emerson, B. M. (2001) Mol. Cell 8, 57–69[Medline] [Order article via Infotrieve]
  12. Ko, L. J., and Prives, C. (1996) Genes Dev. 10, 1054–1072[CrossRef][Medline] [Order article via Infotrieve]
  13. Luo, J., Nikolaev, A. Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L., and Gu, W. (2001) Cell 107, 137–148[Medline] [Order article via Infotrieve]
  14. Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S., Frye, R. A., Pandita, T. K., Guarente, L., and Weinberg, R. A. (2001) Cell 107, 149–159[Medline] [Order article via Infotrieve]
  15. Juan, L. J., Shia, W. J., Chen, M. H., Yang, W. M., Seto, E., Lin, Y. S., and Wu, C. W. (2000) J. Biol. Chem. 275, 20436–20443[Abstract/Free Full Text]
  16. Luo, J., Su, F., Chen, D., Shiloh, A., and Gu, W. (2000) Nature 408, 377–381[CrossRef][Medline] [Order article via Infotrieve]
  17. Barlev, N. A., Liu, L., Chehab, N. H., Mansfield, K., Harris, K. G., Halazonetis, T. D., and Berger, S. L. (2001) Mol. Cell 8, 1243–1254[Medline] [Order article via Infotrieve]
  18. Davies, P. F. (1995) Physiol. Rev. 75, 519–560[Abstract/Free Full Text]
  19. Wissler, R. W. (1995) Am. J. Med. Sci. S29–36
  20. Dimmeler, S., Haendeler, J., Rippmann, V., Nehls, M., and Zeiher, A. M. (1996) FEBS Lett. 399, 71–74[CrossRef][Medline] [Order article via Infotrieve]
  21. Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., and Zeiher, A. M. (1999) Nature 399, 601–605[CrossRef][Medline] [Order article via Infotrieve]
  22. Lin, K., Hsu, P. P., Chen, B. P., Yuan, S., Usami, S., Shyy, J. Y., Li, Y. S., and Chien, S. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 9385–9389[Abstract/Free Full Text]
  23. Akimoto S., Mitsumata, M., Sasaguri, T., and Yoshida Y. (2000) Circ. Res. 86, 185–190[Abstract/Free Full Text]
  24. Liu, X., Miller, C. W., Koeffler, H. P., and Berk, A. J. (1993) Mol. Cell. Biol. 13, 3291–3300[Abstract]
  25. Rössig, L., Li, H., Fisslthaler, B., Urbich, C., Fleming, I., Förstermann, U., Zeiher, A. M., and Dimmeler, S. (2002) Circ. Res. 91, 837–844[Abstract/Free Full Text]
  26. Suzuki, T., Yokozaki, H., Kuniyasu, H., Hayashi, K., Naka, K., Ono, S., Ishikawa, T., Tahara, E., and Yasui, W. (2000) Int. J. Cancer 88, 992–997[CrossRef][Medline] [Order article via Infotrieve]
  27. Xiao, H., Hasegawa, T., and Isobe, K. (2000) J. Biol. Chem. 275, 1371–1376[Abstract/Free Full Text]
  28. Nagashima, M., Shiseki, M., Miura, K., Hagiwara, K., Linke, S. P., Pedeux, R., Wang, X. W., Yokota, J., Riabowol, K., and Harris, C. C. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 9671–9676[Abstract/Free Full Text]
  29. De Ruijter, A. J., Van Gennip, A. H., Caron, H. N., Kemp, S., and Van Kuilenburg, A. B. (2003) Biochem. J. 370, 737–749[CrossRef][Medline] [Order article via Infotrieve]
  30. Narlikar, G. J., Fan, H. Y., and Kingston, R. E. (2002) Cell 22, 475–487
  31. Nakamura, S., Roth, J. A., and Mukhopadhyay, T. (2000) Mol. Cell. Biol. 20, 9391–9398[Abstract/Free Full Text]
  32. Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., and Appella, E. (1998) Genes Dev. 12, 2831–2841[Abstract/Free Full Text]
  33. Sowa, Y., Orita, T., Hiranabe-Minamikawa, S., Nakano, K., Mizuno, T., Nomura, H., and Sakai, T. (1999) Ann. N. Y. Acad. Sci. 886, 195–199[Free Full Text]
  34. Potapova, O., Gorospe, M., Dougherty, R. H., Dean, N. M., Gaarde, W. A., and Holbrook, N. J. (2000) Mol. Cell. Biol. 20, 1713–1722[Abstract/Free Full Text]
  35. Blagosklonny, M. V., Robey, R., Bates, S., and Fojo, T. (2000) J. Clin. Invest. 105, 533–539[Abstract/Free Full Text]
  36. Javelaud, D., and Besancon, F. (2002) J. Biol. Chem. 277, 37949–37954[Abstract/Free Full Text]
  37. Han, Z., Wei, W., Dunaway, S., Darnowski, J. W., Calabresi, P., Sedivy, J., Hendrickson, E. A., Balan, K. V., Pantazis, P., and Wyche, J. H. (2002) J. Biol. Chem. 277, 17154–17160[Abstract/Free Full Text]
  38. Waldman, T., Kinzler, K. W., and Vogelstein, B. (1995) Cancer Res. 55, 5187–5190[Abstract]
  39. Lin, S. J., Jan, K. M., Weinbaum, S., and Chien, S. (1989) Arteriosclerosis 9, 230–236[Abstract]
  40. Yamashita, Y., Shimada, M., Harimoto, N., Rikimaru, T., Shirabe, K., Tanaka, S., and Sugimachi, K. (2003) Int. J. Cancer 103, 572–576[CrossRef][Medline] [Order article via Infotrieve]




This Article
Abstract
Full Text (PDF)
All Versions of this Article:
278/27/24594    most recent
M301955200v1
Purchase Article
View Shopping Cart
Alert me when this article is cited
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Copyright Permissions
Google Scholar
Articles by Zeng, L.
Articles by Shyy, J. Y.-J.
Articles citing this Article
PubMed
PubMed Citation
Articles by Zeng, L.
Articles by Shyy, J. Y.-J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   Biochemistry and Molecular Biology Education 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.